The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH production
- PMID: 11005273
- DOI: 10.1007/BF03343758
The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH production
Abstract
We present a case of a patient suffering from metastatic differentiated thyroid carcinoma (DTC) and insufficient endogenous TSH production suspicious of secondary hypothyroidism. The use of recombinant human TSH (rhTSH) enabled us to administer a therapeutic activity of radioactive iodine (RAI) under maximal TSH-stimulation, achieving a marked decrease in thyroglobulin accompanied by a clinical improvement.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
